The Vector Core provides Rheumatic Diseases Core Center (RDCC) members with several technological? platforms to facilitate over-expression or reduced expression of specific genes, to assist researchers in? understanding the function and interaction of those genes relevant to the study of rheumatic diseases.? These platforms include both recombinant non-viral and viral products that facilitate the transfer of specific? genes into cells of interest. The Vector Core also provides intellectual and technical advice to RDCC? researchers regarding the optimal use and production of these systems.? Despite the wide application of molecular biology to the study of rheumatic diseases, many investigators? do not possess a working knowledge of recombinant vectors. Many of the operational techniques required? for optimal use of these gene transfer vectors are specialized and difficult to acquire without expert? assistance. In addition, the manufacture of these reagents needs to be performed in laboratory space that? has been specifically configured to comply with NIH biological containment guidelines. The requirements for? compliance with these biosafety guidelines inhibit many investigators from pursuing the use of these? valuable reagents. The Vector Core has been established to provide a cost-effective source of these? valuable platforms while minimizing RDCC members' need to spend time and money on new laboratory? space and hiring their own vector experts.? The Specific Aims of the Vector Core are to: 1. Provide a Core laboratory for the development,? construction, purification and characterization of recombinant vectors containing genes relevant to the study? of rheumatic diseases for use as in vitro and in vivo gene transfer reagents. These systems include both? non-viral (expression plasmid) and viral (recombinant retrovirus, recombinant adenovirus, and recombinant? AAV) technologies. 2. Collaborate closely with RDCC researchers to ensure the Vector Core provides the? platforms RDCC members require. 3. Maintain qualified staff and monitor the competition to continually? improve the Vector Core and provide high quality, cost effective products to RDCC members.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR048310-08
Application #
7662389
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2008-08-01
Project End
2011-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
8
Fiscal Year
2008
Total Cost
$68,413
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Nair, Thankam S; Kommareddi, Pavan K; Galano, Maria M et al. (2016) SLC44A2 single nucleotide polymorphisms, isoforms, and expression: Association with severity of Meniere's disease? Genomics 108:201-208
Delaney, Colin; Garg, Sanjay K; Yung, Raymond (2015) Analysis of DNA Methylation by Pyrosequencing. Methods Mol Biol 1343:249-64
Morgan, Rachel; Endres, Judith; Behbahani-Nejad, Nilofar et al. (2015) Expression and function of aminopeptidase N/CD13 produced by fibroblast-like synoviocytes in rheumatoid arthritis: role of CD13 in chemotaxis of cytokine-activated T cells independent of enzymatic activity. Arthritis Rheumatol 67:74-85
McDade, Joel R; Archambeau, Ashley; Michele, Daniel E (2014) Rapid actin-cytoskeleton-dependent recruitment of plasma membrane-derived dysferlin at wounds is critical for muscle membrane repair. FASEB J 28:3660-70
Isozaki, Takeo; Amin, M Asif; Arbab, Ali S et al. (2014) Inhibitor of DNA binding 1 as a secreted angiogenic transcription factor in rheumatoid arthritis. Arthritis Res Ther 16:R68
Kulpa, Deanna A; Del Cid, Natasha; Peterson, Kirsten A et al. (2013) Adaptor protein 1 promotes cross-presentation through the same tyrosine signal in major histocompatibility complex class I as that targeted by HIV-1. J Virol 87:8085-98
Saha, Anjan K; Kappes, Ferdinand; Mundade, Amruta et al. (2013) Intercellular trafficking of the nuclear oncoprotein DEK. Proc Natl Acad Sci U S A 110:6847-52
Kahlenberg, J Michelle; Carmona-Rivera, Carmelo; Smith, Carolyne K et al. (2013) Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol 190:1217-26
Mor-Vaknin, Nirit; Legendre, Maureen; Yu, Yue et al. (2013) Murine colitis is mediated by vimentin. Sci Rep 3:1045
Fu, Jiaqi; Ling, Song; Liu, Ying et al. (2013) A small shared epitope-mimetic compound potently accelerates osteoclast-mediated bone damage in autoimmune arthritis. J Immunol 191:2096-103

Showing the most recent 10 out of 88 publications